Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Mundipharma’s Sedative Agent Anerem Now Available in Japan
August 11, 2020
- Japan Ethical Drug Sales Up 0.9% in June: Crecon
August 11, 2020
- Daiichi Sankyo, AstraZeneca to Team Up for PI of Patritumab Deruxtecan/Tagrisso Combo in EGFR-Mutated NSCLC
August 11, 2020
- Japan’s Diabetic Market to Shrink after Peaking in FY2023: Yano Research
August 11, 2020
- Telomelysin-Keytruda Combo Trial to Begin in US for Head and Neck Cancer: Oncolys
August 11, 2020
- Axcelead Chief Says Small-Molecule Drug Targets More than Doubled in Last Few Years; IPO Eyed in 4-5 Years
August 7, 2020
- Sumitomo Dainippon Eyes 100 Billion Yen Sales from Frontier Biz: President
August 7, 2020
- Some Firms Curbing Supplies of Ethical Povidone-Iodine Products after Osaka COVID-19 Data
August 7, 2020
- Opdivo Eclipses Keytruda Again in July: Encise Drug Sales Ranking
August 7, 2020
- Sales Rep Promotions in June Double against May: Intage
August 7, 2020
- GSK, KM Biologics in Adjuvant Tech Transfer Talks for COVID-19 Vaccines
August 7, 2020
- Torii Gets Japan Option Rights to Verrica’s Warts Drug
August 6, 2020
- MSD Japan Chief Wants Talks with Govt, Re-Pricing Rules Revisited to Help Innovation Thrive
August 6, 2020
- SymBio to Tap Into Global Development of Brincidofovir IV for Post-HSTC Adenovirus Infection
August 6, 2020
- Takara Bio to End License Deal for Oncolytic Viral Immunotherapy with Chinese Firm
August 6, 2020
- Sumitomo Dainippon, Save Medical Link Up on Diabetes App; Approval Eyed in FY2022
August 6, 2020
- LTL Pharma to Take Over Sanofi’s Dellegra in Japan
August 5, 2020
- Astellas’ Q1 Sales Falter 8% on Deal Terminations, COVID-19
August 5, 2020
- Celltrion Poised to Roll Out 20 Biosimilars in Japan over Next 10 Years
August 5, 2020
- Povidone-Iodine Gargle Meds Fly Off Pharmacy Shelves after Osaka COVID-19 Data
August 5, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…